FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
174 letters match. Newest first.
-
DrugsHigley Industries, Inc.
FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.
High risk -
FoodDream Wholesale, Inc
Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.
High risk -
FoodHealthtex Distributors, Inc.
FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.
Medium -
DrugsEzriCare LLC
EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk -
DrugsNational Chemical Laboratories
National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
FoodNatural Relief Inc.
Natural Relief Inc. of Coshocton, Ohio, sold two herbal capsule products as unapproved drugs and had serious supplement manufacturing violations.
High risk -
DrugsALI Pharmaceutical Manufacturing, LLC
FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.
High risk -
DrugsSimilasan AG
Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.
High risk -
FoodOsmosis, LLC
Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.
High risk -
DrugsK.C. Pharmaceuticals Inc.
FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
DrugsJamol Laboratories, Inc.
FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.
High risk -
FoodPorfirios Italian Foods, Inc.
FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.
High risk -
FoodNAFTA Distributors Inc.
NAFTA Distributors, an Ontario, California food importer, had no Foreign Supplier Verification Program for candies, oils and other foods it imports.
Medium -
DrugsMr. Lulu LLC
FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.
High risk -
DrugsRemedyRepack, Inc.
RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.
High risk -
DrugsNew England Life Care, Inc. dba Advanced Compounding Solutions
FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.
High risk -
DrugsSure-Biochem Laboratories, LLC
FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.
High risk -
DrugsPharmedica USA, LLC
FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.
High risk -
DrugsPremier Nutra Pharma Inc.
FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.
High risk -
DrugsOmega Packaging Corp
Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.
High risk -
DrugsFormology Lab Inc.
FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.
High risk -
FoodGolden Bridge Gourmet, Inc. DBA Golden Bridge Enterprises
Golden Bridge Gourmet, a California food importer, had no foreign supplier verification program (FSVP) for many imported foods, FDA says.
Medium -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
FoodZing Brothers LLC
FDA warns Zing Brothers LLC that its dietary supplements were made without required CGMP controls and have misleading labels.
Medium -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
FoodAmerican Chinese Natural Herbs, Inc.
FDA warned Garland, Texas-based American Chinese Natural Herbs, Inc. about adulterated (legally unsafe) dietary supplements made without required manufacturing controls and with mislabeled products.
High risk -
BiologicsMark S. Denker, M.D., PA dba Palm Beach Fertility Center
FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.
High risk -
DrugsAuto-Chlor System LLC
Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.
High risk -
FoodGobwa Exotic Imports Inc.
FDA warns Gobwa Exotic Imports for lacking Foreign Supplier Verification Program for imported produce, spices, cocoa.
Medium -
FoodManzela USA, LLC
FDA found Manzela USA lacked required foreign supplier verification programs for imported corn chips, candy, peanuts, and Haba Enchilada.
Medium -
DrugsNatureLab Corp.
FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.
Medium -
DrugsNephron SC Inc.
Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.
High risk -
DevicesForcemech International LLC
Forcemech International, a powered wheelchair relabeler in Pearland, Texas, lacked quality system procedures and UDI labeling, FDA says.
Medium -
DrugsEksa Mills S.A. de C.V.
FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.
High risk -
DrugsSterling Pharmaceutical Services, LLC
Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.
High risk -
DrugsVirgin Scent Inc. dba Artnaturals
FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.
High risk -
FoodKuzmir Imports Inc.
FDA warns Kuzmir Imports over missing foreign supplier verification program (FSVP) records for imported croutons, nougat spread, cashews.
Medium -
DrugsGreen Wave Analytical, LLC
FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.
High risk -
DevicesUSA Medical LLC
FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.
High risk -
BiologicsVitti Labs, LLC
FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.
High risk -
DrugsDSP Skin Care LLC
FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.
High risk -
DrugsBioiberica, SAU
FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.
High risk -
FoodValley View Milling LLC
Valley View Milling of Seneca, Kansas, made sheep feed with copper at toxic levels that killed or injured sheep, and did not follow its own food safety procedures.
High risk -
FoodLas Dos Californias Inc DBA Dulceria los Cuates
Las Dos Californias Inc, a San Diego food importer, lacked required foreign supplier verification programs for imported candy, seeds and Chamoy.
Medium -
FoodEvans Farms Feed
Evans Farms Feed in Alvin, Texas, made horse feed with fumonisin above FDA's 1 ppm limit, tied to horse illnesses and one death.
High risk -
FoodAgroson’s LLC
Agroson’s LLC lacked required FSVP checks for imported papayas and limes, FDA says.
Medium